All articles tagged with #prescription drugs
TrumpRx.gov, launched to curb prescription costs, has offered discounts on only 54 drugs—many with cheaper generics or other savings options—and remains far from an insurance-friendly tool, with limited awareness; experts say its real impact hinges on scale, broader drug coverage, price transparency, and potential congressional action to codify MFN-style deals into law.
The Trump administration unveiled TrumpRx, a White House-backed website intended to help patients buy prescription drugs directly at discounted rates, as part of a push to address rising healthcare and living costs.
President Trump is rolling out TrumpRx.gov, a government site intended to help Americans buy discounted prescription medicines as part of his broader bid to extract price concessions from drugmakers; experts say the plan could offer some savings but is unlikely to dramatically lower costs or reshape the pharmaceutical market.
President Trump released a health-care framework called the Great Health Care Plan that would lower prescription drug prices, shift ACA subsidies toward Health Savings Accounts, and require price transparency from insurers, hospitals, and physicians. The proposal also seeks congressional passage of a most-favored-nation drug pricing policy and funding for ACA cost-sharing reductions to reduce premiums, though some elements are likely to draw GOP pushback on Capitol Hill.
President Trump unveils The Great Healthcare Plan, promising to lower costs by slashing prescription prices, reducing insurance premiums by redirecting subsidies to individuals, expanding funding for cost-sharing reductions, and enforcing price transparency from insurers and providers, including publishing prices and denial rates to empower consumers.
A new Medicare claims analysis found that about 25% of people with dementia are prescribed risky, brain-altering medications such as antidepressants and antipsychotics, despite longstanding clinical guidelines cautioning against this practice.
In 2026, Medicare beneficiaries will face increased premiums and deductibles, higher out-of-pocket costs for prescription drugs, and new negotiated rates on 10 common medications, making it crucial to review plans and budget accordingly for retirement healthcare expenses.
The article discusses how U.S. seniors increasingly rely on cheaper Canadian and international pharmacies for prescription medications, but recent trade policies, tariffs, and shipment restrictions are making access more difficult and expensive, raising concerns about affordability and safety.
Amazon is introducing vending machines at One Medical clinics in Los Angeles to allow patients to quickly pick up common prescriptions like antibiotics and blood pressure medication, aiming to improve access and reduce delays in medication collection. These kiosks will not dispense controlled substances and will be available at more locations in the future, with added options for phone and video consultations with pharmacists.
The article highlights the struggles of Americans like Janet Kerrigan and Aarolyn McCullough, who face exorbitant costs for essential medications, and discusses President Trump's efforts to lower drug prices through initiatives like Pfizer's Medicaid discounts and the upcoming 'TrumpRx' site, with critics arguing these measures may not go far enough.
Telehealth has evolved from a tool for accessible medical consultations to a major marketing platform for direct-to-consumer drug sales, with ads for various medications like erectile dysfunction and weight loss drugs becoming ubiquitous in city environments, reflecting a shift towards drug-first approaches in digital healthcare.
Donald Trump announced the launch of 'TrumpRx,' a government website allowing Americans to buy prescription drugs directly at potentially lower prices, with Pfizer's involvement and an agreement to sell drugs to Medicaid at reduced rates.
President Trump's announcement of a 100% tariff on foreign brand-name drugs raises questions about which drugs will be affected, potential price increases for patients, the impact on U.S. drug manufacturing, and the risk of shortages, with many uncertainties about exemptions and the timeline for manufacturing changes.
Healthcare inflation is rising, with medical costs increasing by 4.2% in August, leading to potential double-digit premium hikes for consumers and a projected 9% increase in employer health coverage costs in 2026. Expensive drugs, especially cancer and weight loss medications like GLP-1s, are major cost drivers, prompting employers to explore more affordable access options and new payment models to manage rising expenses.
The use of certain prescription drugs, known as fall risk-increasing drugs (FRIDs), has been linked to a tripling of fall-related death rates among seniors in the U.S. over the past 30 years, with medications like opioids, benzodiazepines, and antidepressants contributing to increased fall risks, though further research is needed to establish causation.